Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Attal, Michel; Lauwers‐Cancès, Valérie; Marit, Gérald; Caillot, Denis; Moreau, Philippe; Façon, Thierry; Marie Stoppa, Anne; Hulin, Cyrille; Benboubker, Lofti; Garderet, Laurent; Decaux, Olivier; Leyvraz, Serge; Vekemans, Marie‐Christiane; Voillat, Laurent; Michallet, Mauricette; Pegourié, Brigitte; Dumontet, Charles; Roussel, Murielle; Leleu, Xavier; Mathiot, Claire; Payen, Catherine; Avet‐Loiseau, Hervé; Harousseau, Jean‐Luc

doi:10.1056/nejmoa1114138

Public

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Published in New England Journal of Medicine • May 9, 2012

Authors:

Michel Attal

Valérie Lauwers‐Cancès

Gérald Marit

Abstract

BACKGROUND: High-dose chemotherapy with autologous stem-cell transplantation is a standard treatment for young patients with multiple myeloma. Residual disease is almost always present after transplantation and is responsible for relapse. This phase 3, placebo-controlled trial investigated the effic...

Subject

Lenalidomide

Multiple myeloma

Autologous stem-cell transplantation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!